oxotnik1 • 1 hour 50 minutes ago Flag
5users liked this postsusers disliked this posts0Reply
Copy of Letter SNY sent out to participants of Dec 5th San Diego Meeting (PART 1)
Afrezza Patient Advisory Board
Here is the letter SNY sent out to the Initial Adopters prior to the San Diego (Del Mar) meeting on Dec 5. I had been asked not to share it, but now with SNY out it makes no matter. I've removed the recipient's name per recipient's request. I've broken letter up into two parts, as it would not all fit for some reason. This is part 1. Part 2 will come next.
Dear XXXXXXXXXXXXXXX
Thank you for your willingness to participate in the Sanofi Patient Advisory Board for our upcoming Afrezza study. We are looking forward to a successful meeting in San Diego on December 5th.
Sanofi appreciates your willingness to help us shape the future on insulin delivery and your experience is of utmost importance as we continue our work to better understand dosing needs and guidelines with prandial (mealtime) insulins.
We are learning from individuals that they are using Afrezza together with continuous glucose monitoring (CGM) and are achieving good blood sugar results. We are interested in investigating the use of Afrezza with CGM in a formal clinical study and need your help in the development of instructions for individuals new to Afrezza
and for those on injectable mealtime insulin as well. We believe your experience and perspective will help us to:
· Develop an in-depth understanding of the challenges and barriers as well as the successes related to mealtime insulin
· Provide innovative advice and dynamic perspectives on the use of both inhaled and injectable mealtime insulin in combination with CGM
· Create a blueprint for the design and instructions for the use of Afrezza and injectable mealtime insulin for the Phase 4 study that will be launched by Sanofi in the near future.